Nuchronic Nuchronic

Dark-mode Hacker News-style feed for the chronically ill indie web.

Latest posts from the chronic-illness indie web

  1. 1.

    Interview with George Monbiot on Recent Guardian Column

  2. 2.

    Daily Mail Online share article about recent ME/CFS Research, with comment from Dr Charles Shepherd

  1. Ad.

    Crash Plan: write it on a good day, use it on a bad one. A printable plan for PEM crashes and flare-ups

  1. 3.

    rose ▪ bud ▪ thorn - september 2026

  2. 4.

    October/November Writing Prompts for People with Chronic Illness & Disability (2026 Edition)

  3. 5.

    I interviewed five people with Long COVID in prison. They are invisible in the system.

  4. 6.

    Bioengineer: Lupus Patients With Stubborn Symptoms May Resemble ME/CFS, New Framework Suggests

  5. 7.

    Where To Hire A Tramper In The UK

  6. 8.

    book club: kiss of the spider woman by manuel puig

  7. 9.

    British Psychological Society ME/CFS Guidelines: September 2026 Update

  8. 10.

    Sleep apnea and pain: not the clear link you’d think [3m]

  9. 11.

    Bezisterim – the Best Long COVID Drug Trial Yet? BioVie Aims for a Big, Phase III Trial

  10. 12.

    WeakNotes 2026-09-27

  11. 13.

    book: bad blood by john carreyrou

  12. 14.

    merz bad

  13. 15.

    LBC | Natasha Devon interview with George Monbiot

  14. 16.

    Blistering New Monbiot Column on ME/CFS Mistreatment, Neglect

  15. 17.

    Thinking of the Future Thinking of the Past

  16. 18.

    Journal of Psychosomatic Research Publishes First-Person Account of “Cure” with the Lightning Process

  17. 19.

    Research Update: MEA Clinical Assessment Toolkit (MEA‑CAT) – Stage II

  18. 20.

    Mltply workbooks are on Etsy

  19. 21.

    I've opened a shop

  20. 22.

    elizabeth holmes

  21. 23.

    the reduction of intellectual labor

  22. 24.

    Research: DISCOVER-ME

  23. 25.

    The Sickfluencer Scam : A Threat To Advocacy & Support

  24. 26.

    a source of drain

  25. 27.

    People with Long COVID demand pause of McMaster University clinical trial